Jay Shubrook;Chase A. Scarbrough;Stanley S. Scarbrough
发明人:
Chase A. Scarbrough,Stanley S. Scarbrough,Jay Shubrook
申请号：
US13504799
公开号：
US20120283332A1
申请日:
2010.05.12
申请国别(地区):
US
年份:
2012
代理人:
摘要：
Provided is a transdermal metformin that is an effective alternative treatment modality in patients with insulin resistance. Transdermal metformin can be used in conditions where oral metformin is indicated such as Type 2 diabetes mellitus, pre-diabetes, polycystic ovarian syndrome, and other known diabetes associated disorders. One advantage of using transdermal metformin is its ability to bypass the gastrointestinal system. This allows the drug to not have the gastrointestinal side-effects associated with oral metformin. A surprising advantage of using transdermal metformin in accordance with this disclosure is a 90% decrease in dosage from the oral preparation.
